143 related articles for article (PubMed ID: 11121655)
1. Thallium-201 scintigraphy is not predictive of late cardiac complications in patients with Hodgkin's disease treated with mediastinal radiation.
Girinsky T; Cordova A; Rey A; Cosset JM; Tertian G; Pierga JY
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1503-6. PubMed ID: 11121655
[TBL] [Abstract][Full Text] [Related]
2. Follow-up thallium-201 scintigraphy after mantle field radiotherapy for Hodgkin's disease.
Pierga JY; Maunoury C; Valette H; Socie G; Girinski T; Tchernia G; Henry-Amar M; Desgrez A; Cosset JM
Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):871-6. PubMed ID: 8478238
[TBL] [Abstract][Full Text] [Related]
3. Myocardial perfusion damage after mediastinal irradiation for Hodgkin's disease: a thallium-201 single photon emission tomography study.
Maunoury C; Pierga JY; Valette H; Tchernia G; Cosset JM; Desgrez A
Eur J Nucl Med; 1992; 19(10):871-3. PubMed ID: 1451703
[TBL] [Abstract][Full Text] [Related]
4. Radiation effects on left ventricular function and myocardial perfusion in long term survivors of Hodgkin's disease.
Savage DE; Constine LS; Schwartz RG; Rubin P
Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):721-7. PubMed ID: 2211221
[TBL] [Abstract][Full Text] [Related]
5. Cardiac risk after mediastinal irradiation for Hodgkin's disease.
Glanzmann C; Kaufmann P; Jenni R; Hess OM; Huguenin P
Radiother Oncol; 1998 Jan; 46(1):51-62. PubMed ID: 9488128
[TBL] [Abstract][Full Text] [Related]
6. Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease.
Constine LS; Schwartz RG; Savage DE; King V; Muhs A
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):897-906. PubMed ID: 9369139
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
JAMA; 1993 Oct; 270(16):1949-55. PubMed ID: 8411552
[TBL] [Abstract][Full Text] [Related]
8. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
Chronowski GM; Wilder RB; Tucker SL; Ha CS; Younes A; Fayad L; Rodriguez MA; Hagemeister FB; Barista I; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):36-43. PubMed ID: 12504034
[TBL] [Abstract][Full Text] [Related]
9. 3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures.
Vordermark D; Seufert I; Schwab F; Kölbl O; Kung M; Angermann C; Flentje M
Radiat Oncol; 2006 Apr; 1():10. PubMed ID: 16722610
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of dipyridamole-thallium myocardial scintigraphy in patients with Kawasaki disease.
Miyagawa M; Mochizuki T; Murase K; Tanada S; Ikezoe J; Sekiya M; Hamamoto K; Matsumoto S; Niino M
Circulation; 1998 Sep; 98(10):990-6. PubMed ID: 9737519
[TBL] [Abstract][Full Text] [Related]
11. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
[TBL] [Abstract][Full Text] [Related]
12. Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients.
Zinzani PL; Gherlinzoni F; Piovaccari G; Frezza G; Bendandi M; Ferretti RM; Barbieri E; Fiacchini M; Babini L; Magnani B; Tura S
Haematologica; 1996; 81(2):132-7. PubMed ID: 8641641
[TBL] [Abstract][Full Text] [Related]
13. Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease.
Gustavsson A; Eskilsson J; Landberg T; Svahn-Tapper G; White T; Wollmer P; Akerman M
Ann Oncol; 1990 Sep; 1(5):355-63. PubMed ID: 2261376
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease.
King V; Constine LS; Clark D; Schwartz RG; Muhs AG; Henzler M; Hutson A; Rubin P
Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):881-9. PubMed ID: 8960517
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
[TBL] [Abstract][Full Text] [Related]
16. Cardiac lesions after mediastinal irradiation for Hodgkin's disease.
Glanzmann C; Huguenin P; Lütolf UM; Maire R; Jenni R; Gumppenberg V
Radiother Oncol; 1994 Jan; 30(1):43-54. PubMed ID: 8153379
[TBL] [Abstract][Full Text] [Related]
17. Cardiac disease following treatment of Hodgkin's disease in children and adolescents.
Hancock SL; Donaldson SS; Hoppe RT
J Clin Oncol; 1993 Jul; 11(7):1208-15. PubMed ID: 8315419
[TBL] [Abstract][Full Text] [Related]
18. Myocardial perfusion scintigraphy in patients undergoing major non-vascular abdominal surgery.
Mumtaz H; Bomanji JB; Gupta NK; Davidson T; Costa DC; Taylor I; Ell PJ
Ann R Coll Surg Engl; 1996 Sep; 78(5):420-5. PubMed ID: 8881723
[TBL] [Abstract][Full Text] [Related]
19. Incremental prognostic value of exercise thallium-201 myocardial single-photon emission computed tomography late after coronary artery bypass surgery.
Palmas W; Bingham S; Diamond GA; Denton TA; Kiat H; Friedman JD; Scarlata D; Maddahi J; Cohen I; Berman DS
J Am Coll Cardiol; 1995 Feb; 25(2):403-9. PubMed ID: 7829794
[TBL] [Abstract][Full Text] [Related]
20. [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina].
Astarita C; Nicolai E; Liguori E; Gambardella S; Rumolo S; Maresca FS
G Ital Cardiol; 1998 Sep; 28(9):996-1004. PubMed ID: 9788038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
